Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Jacquemin

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|May 11, 2023
Impairment of Angiogenesis-Driven Clot Resolution Is a Key Event in the Progression to Chronic Thromboembolic Pulmonary Hypertension: Validation in a Novel Rabbit ModelRozenn Quarck, Lynn Willems, Birger Tielemans, et al.
Platelets|September 17, 2011
A randomized clinical trial comparing point-of-care platelet function assays and bleeding time in healthy subjects treated with aspirin or clopidogrelFabian Chen, Victor Maridakis, Edward A O'neill, et al.
Molecular Immunology|October 9, 2009
Kinetics and thermodynamics of interaction of coagulation factor VIII with a pathogenic human antibodyJordan D Dimitrov, Lubka T Roumenina, Sebastien Andre, et al.
Journal of Thrombosis and Haemostasis : JTH|November 24, 2019
Von Willebrand factor and ADAMTS13 impact on the outcome of Staphylococcus aureus sepsisMarijke Peetermans, Severien Meyers, Laurens Liesenborghs, et al.
Blood|October 24, 2002
CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia AMarc Jacquemin, Valérie Vantomme, Cécile Buhot, et al.
Thrombosis and Haemostasis|April 4, 2018
Targeting Coagulase Activity in Staphylococcus aureus Bacteraemia: A Randomized Controlled Single-Centre Trial of Staphylothrombin InhibitionMarijke Peetermans, Laurens Liesenborghs, Kathelijne Peerlinck, et al.
Journal of Thrombosis and Haemostasis : JTH|May 28, 2025
Genotype vs laboratory phenotype correlation of defects in natural anticoagulants in patients with venous thromboembolismChristine Van Laer, Marthe Vanrenterghem, Marc Jacquemin, et al.
Journal of Thrombosis and Haemostasis : JTH|January 12, 2025
Multigene panel for thrombophilia testing in venous thromboembolismAndreas Verstraete, Mae Jeraldine De Vera, Christine Van Laer, et al.
Clinical Therapeutics|July 20, 2010
Tolerability and pharmacokinetics of TB-402 in healthy male volunteersPeter Verhamme, Steve Pakola, Thomas J Jensen, et al.
Journal of Thrombosis and Haemostasis : JTH|July 7, 2026
Direct oral anticoagulant use and drug-drug interactions in transplant recipients receiving calcineurin inhibitorsAndreas Verstraete, Erwin Dreesen, Quentin Van Thillo, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Arteriosclerosis, Thrombosis, and Vascular Biology|May 11, 2023
Impairment of Angiogenesis-Driven Clot Resolution Is a Key Event in the Progression to Chronic Thromboembolic Pulmonary Hypertension: Validation in a Novel Rabbit ModelRozenn Quarck, Lynn Willems, Birger Tielemans, et al.
Platelets|September 17, 2011
A randomized clinical trial comparing point-of-care platelet function assays and bleeding time in healthy subjects treated with aspirin or clopidogrelFabian Chen, Victor Maridakis, Edward A O'neill, et al.
Molecular Immunology|October 9, 2009
Kinetics and thermodynamics of interaction of coagulation factor VIII with a pathogenic human antibodyJordan D Dimitrov, Lubka T Roumenina, Sebastien Andre, et al.
Journal of Thrombosis and Haemostasis : JTH|November 24, 2019
Von Willebrand factor and ADAMTS13 impact on the outcome of Staphylococcus aureus sepsisMarijke Peetermans, Severien Meyers, Laurens Liesenborghs, et al.
Blood|October 24, 2002
CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia AMarc Jacquemin, Valérie Vantomme, Cécile Buhot, et al.
Thrombosis and Haemostasis|April 4, 2018
Targeting Coagulase Activity in Staphylococcus aureus Bacteraemia: A Randomized Controlled Single-Centre Trial of Staphylothrombin InhibitionMarijke Peetermans, Laurens Liesenborghs, Kathelijne Peerlinck, et al.
Journal of Thrombosis and Haemostasis : JTH|May 28, 2025
Genotype vs laboratory phenotype correlation of defects in natural anticoagulants in patients with venous thromboembolismChristine Van Laer, Marthe Vanrenterghem, Marc Jacquemin, et al.
Journal of Thrombosis and Haemostasis : JTH|January 12, 2025
Multigene panel for thrombophilia testing in venous thromboembolismAndreas Verstraete, Mae Jeraldine De Vera, Christine Van Laer, et al.
Clinical Therapeutics|July 20, 2010
Tolerability and pharmacokinetics of TB-402 in healthy male volunteersPeter Verhamme, Steve Pakola, Thomas J Jensen, et al.
Journal of Thrombosis and Haemostasis : JTH|July 7, 2026
Direct oral anticoagulant use and drug-drug interactions in transplant recipients receiving calcineurin inhibitorsAndreas Verstraete, Erwin Dreesen, Quentin Van Thillo, et al.
Pageof 6